Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00565487
Recruitment Status : Unknown
Verified November 2012 by Yixing Jiang, Penn State University.
Recruitment status was:  Active, not recruiting
First Posted : November 30, 2007
Last Update Posted : December 3, 2012
Genentech, Inc.
Information provided by (Responsible Party):
Yixing Jiang, Penn State University

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2013
  Estimated Study Completion Date : December 2013